Life ScienceCompany
Bristol-Myers Squibb M&A Summary
Bristol-Myers Squibb has acquired 24 companies, including 7 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 13 assets.
Bristol-Myers Squibb’s largest acquisition to date was in 2019, when it acquired Celgene for $74.0B. It’s largest disclosed sale occurred in 2001, when it sold Clairol to The Procter & Gamble for $5.0B. Bristol-Myers Squibb has acquired in 8 different US states, and 4 countries. The Company’s most targeted sectors include life science (100%).
Bristol-Myers Squibb Business Overview
Where is Bristol-Myers Squibb headquartered?
Bristol-Myers Squibb is headquartered in New York, New York.
What is Bristol-Myers Squibb’s revenue?
Bristol-Myers Squibb disclosed revenue of 46,159M USD for 2022 and 46,385M USD for 2021.
How many employees does Bristol-Myers Squibb have?
Bristol-Myers Squibb has 32,200 employees.
What sector is Bristol-Myers Squibb in?
Bristol-Myers Squibb is a life science company.
When was Bristol-Myers Squibb founded?
Bristol-Myers Squibb was founded in 1887.
M&A Summary
-
M&A Total Activity36
- M&A Buy Activity23
- M&A Sell Activity13
- Total Sectors Invested 1
- Total Countries Invested 4
- M&A Buy/Sell Connections 16
- M&A Advisors 11
Unlimited Searches
